Yoo et al. demonstrated that circulating LECT2 levels were significantly associated with NAFLD (p < 0.001) and metabolic syndrome (p = 0.016) caused by mediating dyslipidemia and abdominal obesity [25]. The gene discussed is LECT2; the disease is metabolic dysfunction-associated steatotic liver disease.